` ALBT (Avalon Globocare Corp) vs S&P 500 Comparison - Alpha Spread

ALBT
vs
S&P 500

Over the past 12 months, ALBT has underperformed S&P 500, delivering a return of -59% compared to the S&P 500's 9% growth.

Stocks Performance
ALBT vs S&P 500

Loading
ALBT
S&P 500
Add Stock

Performance Gap
ALBT vs S&P 500

Performance Gap Between ALBT and GSPC
HIDDEN
Show

Performance By Year
ALBT vs S&P 500

Loading
ALBT
S&P 500
Add Stock

Competitors Performance
Avalon Globocare Corp vs Peers

Avalon Globocare Corp
Glance View

Market Cap
5.5m USD
Industry
Health Care

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm is focused on the fields of cellular immunotherapy, including CAR-T/NK; exosome technology (ACTEX), and COVID-19-related vaccine and therapeutics through its subsidiaries. The company operates through two business segments: real property operating segment and medical related consulting services segment. The firm also provides strategic advisory and outsourcing services to facilitate and improve its clients’ growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its clinical programs include AVA-001, ACTEX, FLASH-CAR, and AVA-Trap.

ALBT Intrinsic Value
HIDDEN
Show
Back to Top